Drug Profile


Alternative Names: Vedrop

Latest Information Update: 09 Jul 2012

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Orphan Europe
  • Class Tocopherols
  • Mechanism of Action Vitamin E agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Vitamin deficiency

Most Recent Events

  • 05 Jul 2012 Tocofersolan licensed to Medunik in Canada
  • 27 Jan 2009 The Committee for Medicinal Products for Human Use recommends the refusal of a marketing authorisation for tocofersolan for the treatment of vitamin E deficiency due to digestive malabsorption in children with cystic fibrosis and chronic cholestasis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top